Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review.
Frontiers in Psychiatry 2025 Mary R. Shen, Dylan E Campbell, Anika Kopczynski et al. 10 citations
Opioid use disorder (OUD) continues to be a public health crisis in the United States, with mortality having doubled over the last twenty years, leading to significant economic cost, morbidity, and mortality. This has caused significant demand for novel therapeutics. Preliminary evidence demonstrates that ketamine may be helpful in treating OUD as well as serve as an adjunct during treatment of...
DOI: 10.3389/fpsyt.2025.1552084 (opens in new tab)
Full text (opens in new tab)
Opioid use disorder
Nmda antagonist
Opioid withdrawal
Addiction treatment
+5